KEGG   DRUG: Rovelizumab
Entry
D08993                      Drug                                   

Name
Rovelizumab (USAN/INN)
Efficacy
Anti-ischemic, Immunosuppressant, Anti-CD11/CD18 antibody
Comment
Monoclonal antibody
Target
ITGAL (CD11A) [HSA:3683] [KO:K05718]
ITGAM (CD11B) [HSA:3684] [KO:K06461]
ITGB2 (CD18) [HSA:3689] [KO:K06464]
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Cell adhesion molecules: other families
   Integrins
    ITGAL (CD11A)
     D08993  Rovelizumab (USAN/INN)
    ITGAM (CD11B)
     D08993  Rovelizumab (USAN/INN)
    ITGB2 (CD18)
     D08993  Rovelizumab (USAN/INN)
Other DBs
CAS: 197099-66-4
PubChem: 96025676
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system